CIK 1799883
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 81.35% | 16 |
| Unclassified | 14.90% | 3 |
| Life Sciences Tools & Services | 3.76% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ERAS | Erasca, Inc. | Health Care | 15.66% |
| 2 | TRDA | Entrada Therapeutics, Inc. | Health Care | 14.21% |
| 3 | TYRA | Tyra Biosciences, Inc. | Health Care | 10.94% |
| 4 | CAMP | Camp4 Therapeutics Corp | Health Care | 7.19% |
| 5 | CENTESSA PHARMACEUTICALS PLC | Unclassified | 6.41% | |
| 6 | PHVS | PHARVARIS N V | Unclassified | 6.26% |
| 7 | MPLT | MapLight Therapeutics, Inc. | Health Care | 5.36% |
| 8 | TECX | Tectonic Therapeutic, Inc. | Health Care | 5.21% |
| 9 | CLDX | Celldex Therapeutics, Inc. | Health Care | 4.38% |
| 10 | ARTV | Artiva Biotherapeutics, Inc. | Health Care | 4.21% |
17/20 names classified · sector 85.1% of weight · industry 85.1% · mkt cap 85.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 85.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/20 names) · unclassified 100.0%: ERAS, TRDA, TYRA, CAMP, , PHVS, MPLT, TECX, CLDX, ARTV +10 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ERASERASCA INC | 3,485,971 | $56M | 15.7% | TRIM −36% |
| 2 | TRDAENTRADA THERAPEUTICS INC | 4,056,379 | $51M | 14.2% | HOLD |
| 3 | TYRATYRA BIOSCIENCES INC | 1,029,298 | $39M | 10.9% | HOLD |
| 4 | CAMPCAMP4 THERAPEUTICS CORP | 5,869,091 | $26M | 7.2% | HOLD |
| 5 | CENTESSA PHARMACEUTICALS PLC | 580,945 | $23M | 6.4% | HOLD |
| 6 | PHVSPHARVARIS N V | 797,600 | $23M | 6.3% | HOLD |
| 7 | MPLTMAPLIGHT THERAPEUTICS INC | 950,011 | $19M | 5.4% | HOLD |
| 8 | TECXTECTONIC THERAPEUTIC INC | 606,660 | $19M | 5.2% | HOLD |
| 9 | CLDXCELLDEX THERAPEUTICS INC NEW | 497,270 | $16M | 4.4% | HOLD |
| 10 | ARTVARTIVA BIOTHERAPEUTICS INC | 2,353,304 | $15M | 4.2% | HOLD |
| 11 | EYPTEYEPOINT INC | 1,050,000 | $14M | 3.8% | HOLD |
| 12 | SRZNSURROZEN INC | 387,500 | $11M | 3.1% | HOLD |
| 13 | ZNTLZENTALIS PHARMACEUTICALS INC | 3,947,913 | $9M | 2.6% | HOLD |
| 14 | GHRSGH RESEARCH PLC | 572,665 | $8M | 2.2% | HOLD |
| 15 | TARAPROTARA THERAPEUTICS INC | 1,369,782 | $7M | 2.0% | HOLD |
| 16 | BHVNBIOHAVEN LTD | 738,972 | $6M | 1.7% | HOLD |
| 17 | ALXOALX ONCOLOGY HLDGS INC | 3,057,325 | $6M | 1.7% | NEW |
| 18 | SKYESKYE BIOSCIENCE INC | 9,681,763 | $6M | 1.7% | HOLD |
| 19 | RLYBRALLYBIO CORP | 291,788 | $3M | 0.7% | NEW |
| 20 | SLNSILENCE THERAPEUTICS PLC | 476,200 | $3M | 0.7% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| ERASERASCA INC | 5.4M | 5.4M | 5.4M | 5.4M | 5.4M | 3.5M | $56M |
| TRDAENTRADA THERAPEUTICS INC | 4.4M | 4.4M | 4.3M | 4.3M | 4.1M | 4.1M | $51M |
| TYRATYRA BIOSCIENCES INC | 939K | 939K | 939K | 939K | 1.0M | 1.0M | $39M |
| CAMPCAMP4 THERAPEUTICS CORP | 2.9M | 2.9M | 2.9M | 5.9M | 5.9M | 5.9M | $26M |
| CENTESSA PHARMACEUTICALS PLC | 831K | 831K | 831K | 681K | 581K | 581K | $23M |
| PHVSPHARVARIS N V | 798K | 798K | 798K | 798K | 798K | 798K | $23M |
| MPLTMAPLIGHT THERAPEUTICS INC | — | — | — | — | 950K | 950K | $19M |
| TECXTECTONIC THERAPEUTIC INC | 597K | 512K | 512K | 512K | 607K | 607K | $19M |
| CLDXCELLDEX THERAPEUTICS INC NEW | 497K | 497K | 497K | 497K | 497K | 497K | $16M |
| ARTVARTIVA BIOTHERAPEUTICS INC | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | $15M |
| EYPTEYEPOINT INC | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | $14M |
| SRZNSURROZEN INC | — | 310K | 310K | 310K | 388K | 388K | $11M |
| ZNTLZENTALIS PHARMACEUTICALS INC | 490K | 490K | 490K | 490K | 3.9M | 3.9M | $9M |
| GHRSGH RESEARCH PLC | 573K | 573K | 573K | 573K | 573K | 573K | $8M |
| TARAPROTARA THERAPEUTICS INC | 800K | 800K | 800K | 800K | 1.4M | 1.4M | $7M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
